Aquinox Announces Topline Results of Phase 3 LEADERSHIP 301 Clinical Trial in Interstitial Cystitis/Bladder Pain Syndrome Read more
Sanofi completes its acquisition of Ablynx following the expiration of the Squeeze-out Procedure Read more
Merck Signs Exclusive Agreement with HistoCyte Laboratories to Distribute Pathology Technology Read more
Janssen’s Tremfya (guselkumab) receives its first two positive Health Technology Assessments in Europe Read more
Asterias Biotherapeutics Announces First Patient Dosed in First-in-Human Clinical Study of Immunotherapy AST-VAC2 in Non-Small Cell Lung Cancer Read more
GE Healthcare FlexFactory Helps XPH Scale Up Industrialization of TCR T-Cell Immunotherapy Drugs Read more
Blueprint Medicines and CStone Pharmaceuticals Announce Exclusive Collaboration and License Agreement Read more